Global Nano-Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Nano-Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Nano-Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Nano-Drug by Country/Region, 2017, 2022 & 2028

2.2 Nano-Drug Segment by Type

2.2.1 Liposomes

2.2.2 Polymeric Micelles

2.2.3 Solid lipid Nanoparticles

2.2.4 Microemulsion and Nanoemulsion

2.2.5 Nanosuspension

2.3 Nano-Drug Sales by Type

2.3.1 Global Nano-Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Nano-Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Nano-Drug Sale Price by Type (2017-2022)

2.4 Nano-Drug Segment by Application

2.4.1 Cancer and Tumors

2.4.2 Autoimmune Disorders

2.5 Nano-Drug Sales by Application

2.5.1 Global Nano-Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Nano-Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Nano-Drug Sale Price by Application (2017-2022)

3 Global Nano-Drug by Company

3.1 Global Nano-Drug Breakdown Data by Company

3.1.1 Global Nano-Drug Annual Sales by Company (2020-2022)

3.1.2 Global Nano-Drug Sales Market Share by Company (2020-2022)

3.2 Global Nano-Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Nano-Drug Revenue by Company (2020-2022)

3.2.2 Global Nano-Drug Revenue Market Share by Company (2020-2022)

3.3 Global Nano-Drug Sale Price by Company

3.4 Key Manufacturers Nano-Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Nano-Drug Product Location Distribution

3.4.2 Players Nano-Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Nano-Drug by Geographic Region

4.1 World Historic Nano-Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Nano-Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Nano-Drug Annual Revenue by Geographic Region

4.2 World Historic Nano-Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Nano-Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Nano-Drug Annual Revenue by Country/Region

4.3 Americas Nano-Drug Sales Growth

4.4 APAC Nano-Drug Sales Growth

4.5 Europe Nano-Drug Sales Growth

4.6 Middle East & Africa Nano-Drug Sales Growth

5 Americas

5.1 Americas Nano-Drug Sales by Country

5.1.1 Americas Nano-Drug Sales by Country (2017-2022)

5.1.2 Americas Nano-Drug Revenue by Country (2017-2022)

5.2 Americas Nano-Drug Sales by Type

5.3 Americas Nano-Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Nano-Drug Sales by Region

6.1.1 APAC Nano-Drug Sales by Region (2017-2022)

6.1.2 APAC Nano-Drug Revenue by Region (2017-2022)

6.2 APAC Nano-Drug Sales by Type

6.3 APAC Nano-Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Nano-Drug by Country

7.1.1 Europe Nano-Drug Sales by Country (2017-2022)

7.1.2 Europe Nano-Drug Revenue by Country (2017-2022)

7.2 Europe Nano-Drug Sales by Type

7.3 Europe Nano-Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Nano-Drug by Country

8.1.1 Middle East & Africa Nano-Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Nano-Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Nano-Drug Sales by Type

8.3 Middle East & Africa Nano-Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Nano-Drug

10.3 Manufacturing Process Analysis of Nano-Drug

10.4 Industry Chain Structure of Nano-Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Nano-Drug Distributors

11.3 Nano-Drug Customer

12 World Forecast Review for Nano-Drug by Geographic Region

12.1 Global Nano-Drug Market Size Forecast by Region

12.1.1 Global Nano-Drug Forecast by Region (2023-2028)

12.1.2 Global Nano-Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Nano-Drug Forecast by Type

12.7 Global Nano-Drug Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Nano-Drug Product Offered

13.1.3 Merck Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Nano-Drug Product Offered

13.2.3 Pfizer Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Novartis

13.3.1 Novartis Company Information

13.3.2 Novartis Nano-Drug Product Offered

13.3.3 Novartis Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Novartis Main Business Overview

13.3.5 Novartis Latest Developments

13.4 Abbott

13.4.1 Abbott Company Information

13.4.2 Abbott Nano-Drug Product Offered

13.4.3 Abbott Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Abbott Main Business Overview

13.4.5 Abbott Latest Developments

13.5 GlaxoSmithKline

13.5.1 GlaxoSmithKline Company Information

13.5.2 GlaxoSmithKline Nano-Drug Product Offered

13.5.3 GlaxoSmithKline Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKline Main Business Overview

13.5.5 GlaxoSmithKline Latest Developments

13.6 Roche

13.6.1 Roche Company Information

13.6.2 Roche Nano-Drug Product Offered

13.6.3 Roche Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Roche Main Business Overview

13.6.5 Roche Latest Developments

13.7 Sanofi

13.7.1 Sanofi Company Information

13.7.2 Sanofi Nano-Drug Product Offered

13.7.3 Sanofi Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sanofi Main Business Overview

13.7.5 Sanofi Latest Developments

13.8 Eli Lilly

13.8.1 Eli Lilly Company Information

13.8.2 Eli Lilly Nano-Drug Product Offered

13.8.3 Eli Lilly Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Eli Lilly Main Business Overview

13.8.5 Eli Lilly Latest Developments

13.9 Astrazeneca

13.9.1 Astrazeneca Company Information

13.9.2 Astrazeneca Nano-Drug Product Offered

13.9.3 Astrazeneca Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Astrazeneca Main Business Overview

13.9.5 Astrazeneca Latest Developments

13.10 Johnson & Johnson

13.10.1 Johnson & Johnson Company Information

13.10.2 Johnson & Johnson Nano-Drug Product Offered

13.10.3 Johnson & Johnson Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Johnson & Johnson Main Business Overview

13.10.5 Johnson & Johnson Latest Developments

13.11 Celgene

13.11.1 Celgene Company Information

13.11.2 Celgene Nano-Drug Product Offered

13.11.3 Celgene Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Celgene Main Business Overview

13.11.5 Celgene Latest Developments

13.12 Novavax

13.12.1 Novavax Company Information

13.12.2 Novavax Nano-Drug Product Offered

13.12.3 Novavax Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Novavax Main Business Overview

13.12.5 Novavax Latest Developments

13.13 Stryker

13.13.1 Stryker Company Information

13.13.2 Stryker Nano-Drug Product Offered

13.13.3 Stryker Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Stryker Main Business Overview

13.13.5 Stryker Latest Developments

13.14 Gilead Sciences

13.14.1 Gilead Sciences Company Information

13.14.2 Gilead Sciences Nano-Drug Product Offered

13.14.3 Gilead Sciences Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Gilead Sciences Main Business Overview

13.14.5 Gilead Sciences Latest Developments

13.15 OSI Pharmaceuticals

13.15.1 OSI Pharmaceuticals Company Information

13.15.2 OSI Pharmaceuticals Nano-Drug Product Offered

13.15.3 OSI Pharmaceuticals Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 OSI Pharmaceuticals Main Business Overview

13.15.5 OSI Pharmaceuticals Latest Developments

13.16 Kadmon Pharmaceuticals

13.16.1 Kadmon Pharmaceuticals Company Information

13.16.2 Kadmon Pharmaceuticals Nano-Drug Product Offered

13.16.3 Kadmon Pharmaceuticals Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Kadmon Pharmaceuticals Main Business Overview

13.16.5 Kadmon Pharmaceuticals Latest Developments

13.17 Samyang Biopharm

13.17.1 Samyang Biopharm Company Information

13.17.2 Samyang Biopharm Nano-Drug Product Offered

13.17.3 Samyang Biopharm Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Samyang Biopharm Main Business Overview

13.17.5 Samyang Biopharm Latest Developments

13.18 Mitsubishi Pharma

13.18.1 Mitsubishi Pharma Company Information

13.18.2 Mitsubishi Pharma Nano-Drug Product Offered

13.18.3 Mitsubishi Pharma Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Mitsubishi Pharma Main Business Overview

13.18.5 Mitsubishi Pharma Latest Developments

13.19 Kaken Pharmaceutical

13.19.1 Kaken Pharmaceutical Company Information

13.19.2 Kaken Pharmaceutical Nano-Drug Product Offered

13.19.3 Kaken Pharmaceutical Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Kaken Pharmaceutical Main Business Overview

13.19.5 Kaken Pharmaceutical Latest Developments

13.20 Selecta Biosciences

13.20.1 Selecta Biosciences Company Information

13.20.2 Selecta Biosciences Nano-Drug Product Offered

13.20.3 Selecta Biosciences Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Selecta Biosciences Main Business Overview

13.20.5 Selecta Biosciences Latest Developments

13.21 Par Pharmaceutical

13.21.1 Par Pharmaceutical Company Information

13.21.2 Par Pharmaceutical Nano-Drug Product Offered

13.21.3 Par Pharmaceutical Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Par Pharmaceutical Main Business Overview

13.21.5 Par Pharmaceutical Latest Developments

13.22 Cerulean Pharma

13.22.1 Cerulean Pharma Company Information

13.22.2 Cerulean Pharma Nano-Drug Product Offered

13.22.3 Cerulean Pharma Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Cerulean Pharma Main Business Overview

13.22.5 Cerulean Pharma Latest Developments

13.23 Navidea Biopharmaceuticals

13.23.1 Navidea Biopharmaceuticals Company Information

13.23.2 Navidea Biopharmaceuticals Nano-Drug Product Offered

13.23.3 Navidea Biopharmaceuticals Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Navidea Biopharmaceuticals Main Business Overview

13.23.5 Navidea Biopharmaceuticals Latest Developments

13.24 Lummy

13.24.1 Lummy Company Information

13.24.2 Lummy Nano-Drug Product Offered

13.24.3 Lummy Nano-Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Lummy Main Business Overview

13.24.5 Lummy Latest Developments

14 Research Findings and Conclusion

Table 1. Nano-Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Nano-Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Liposomes

Table 4. Major Players of Polymeric Micelles

Table 5. Major Players of Solid lipid Nanoparticles

Table 6. Major Players of Microemulsion and Nanoemulsion

Table 7. Major Players of Nanosuspension

Table 8. Global Nano-Drug Sales by Type (2017-2022) & (K Doses)

Table 9. Global Nano-Drug Sales Market Share by Type (2017-2022)

Table 10. Global Nano-Drug Revenue by Type (2017-2022) & ($ million)

Table 11. Global Nano-Drug Revenue Market Share by Type (2017-2022)

Table 12. Global Nano-Drug Sale Price by Type (2017-2022) & (USD/Dose)

Table 13. Global Nano-Drug Sales by Application (2017-2022) & (K Doses)

Table 14. Global Nano-Drug Sales Market Share by Application (2017-2022)

Table 15. Global Nano-Drug Revenue by Application (2017-2022)

Table 16. Global Nano-Drug Revenue Market Share by Application (2017-2022)

Table 17. Global Nano-Drug Sale Price by Application (2017-2022) & (USD/Dose)

Table 18. Global Nano-Drug Sales by Company (2020-2022) & (K Doses)

Table 19. Global Nano-Drug Sales Market Share by Company (2020-2022)

Table 20. Global Nano-Drug Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Nano-Drug Revenue Market Share by Company (2020-2022)

Table 22. Global Nano-Drug Sale Price by Company (2020-2022) & (USD/Dose)

Table 23. Key Manufacturers Nano-Drug Producing Area Distribution and Sales Area

Table 24. Players Nano-Drug Products Offered

Table 25. Nano-Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Nano-Drug Sales by Geographic Region (2017-2022) & (K Doses)

Table 29. Global Nano-Drug Sales Market Share Geographic Region (2017-2022)

Table 30. Global Nano-Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Nano-Drug Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Nano-Drug Sales by Country/Region (2017-2022) & (K Doses)

Table 33. Global Nano-Drug Sales Market Share by Country/Region (2017-2022)

Table 34. Global Nano-Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Nano-Drug Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Nano-Drug Sales by Country (2017-2022) & (K Doses)

Table 37. Americas Nano-Drug Sales Market Share by Country (2017-2022)

Table 38. Americas Nano-Drug Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Nano-Drug Revenue Market Share by Country (2017-2022)

Table 40. Americas Nano-Drug Sales by Type (2017-2022) & (K Doses)

Table 41. Americas Nano-Drug Sales Market Share by Type (2017-2022)

Table 42. Americas Nano-Drug Sales by Application (2017-2022) & (K Doses)

Table 43. Americas Nano-Drug Sales Market Share by Application (2017-2022)

Table 44. APAC Nano-Drug Sales by Region (2017-2022) & (K Doses)

Table 45. APAC Nano-Drug Sales Market Share by Region (2017-2022)

Table 46. APAC Nano-Drug Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Nano-Drug Revenue Market Share by Region (2017-2022)

Table 48. APAC Nano-Drug Sales by Type (2017-2022) & (K Doses)

Table 49. APAC Nano-Drug Sales Market Share by Type (2017-2022)

Table 50. APAC Nano-Drug Sales by Application (2017-2022) & (K Doses)

Table 51. APAC Nano-Drug Sales Market Share by Application (2017-2022)

Table 52. Europe Nano-Drug Sales by Country (2017-2022) & (K Doses)

Table 53. Europe Nano-Drug Sales Market Share by Country (2017-2022)

Table 54. Europe Nano-Drug Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Nano-Drug Revenue Market Share by Country (2017-2022)

Table 56. Europe Nano-Drug Sales by Type (2017-2022) & (K Doses)

Table 57. Europe Nano-Drug Sales Market Share by Type (2017-2022)

Table 58. Europe Nano-Drug Sales by Application (2017-2022) & (K Doses)

Table 59. Europe Nano-Drug Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Nano-Drug Sales by Country (2017-2022) & (K Doses)

Table 61. Middle East & Africa Nano-Drug Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Nano-Drug Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Nano-Drug Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Nano-Drug Sales by Type (2017-2022) & (K Doses)

Table 65. Middle East & Africa Nano-Drug Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Nano-Drug Sales by Application (2017-2022) & (K Doses)

Table 67. Middle East & Africa Nano-Drug Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Nano-Drug

Table 69. Key Market Challenges & Risks of Nano-Drug

Table 70. Key Industry Trends of Nano-Drug

Table 71. Nano-Drug Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Nano-Drug Distributors List

Table 74. Nano-Drug Customer List

Table 75. Global Nano-Drug Sales Forecast by Region (2023-2028) & (K Doses)

Table 76. Global Nano-Drug Sales Market Forecast by Region

Table 77. Global Nano-Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Nano-Drug Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Nano-Drug Sales Forecast by Country (2023-2028) & (K Doses)

Table 80. Americas Nano-Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Nano-Drug Sales Forecast by Region (2023-2028) & (K Doses)

Table 82. APAC Nano-Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Nano-Drug Sales Forecast by Country (2023-2028) & (K Doses)

Table 84. Europe Nano-Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Nano-Drug Sales Forecast by Country (2023-2028) & (K Doses)

Table 86. Middle East & Africa Nano-Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Nano-Drug Sales Forecast by Type (2023-2028) & (K Doses)

Table 88. Global Nano-Drug Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Nano-Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Nano-Drug Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Nano-Drug Sales Forecast by Application (2023-2028) & (K Doses)

Table 92. Global Nano-Drug Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Nano-Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Nano-Drug Revenue Market Share Forecast by Application (2023-2028)

Table 95. Merck Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 96. Merck Nano-Drug Product Offered

Table 97. Merck Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 98. Merck Main Business

Table 99. Merck Latest Developments

Table 100. Pfizer Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 101. Pfizer Nano-Drug Product Offered

Table 102. Pfizer Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 103. Pfizer Main Business

Table 104. Pfizer Latest Developments

Table 105. Novartis Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 106. Novartis Nano-Drug Product Offered

Table 107. Novartis Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 108. Novartis Main Business

Table 109. Novartis Latest Developments

Table 110. Abbott Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 111. Abbott Nano-Drug Product Offered

Table 112. Abbott Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 113. Abbott Main Business

Table 114. Abbott Latest Developments

Table 115. GlaxoSmithKline Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 116. GlaxoSmithKline Nano-Drug Product Offered

Table 117. GlaxoSmithKline Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 118. GlaxoSmithKline Main Business

Table 119. GlaxoSmithKline Latest Developments

Table 120. Roche Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 121. Roche Nano-Drug Product Offered

Table 122. Roche Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 123. Roche Main Business

Table 124. Roche Latest Developments

Table 125. Sanofi Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 126. Sanofi Nano-Drug Product Offered

Table 127. Sanofi Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 128. Sanofi Main Business

Table 129. Sanofi Latest Developments

Table 130. Eli Lilly Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 131. Eli Lilly Nano-Drug Product Offered

Table 132. Eli Lilly Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 133. Eli Lilly Main Business

Table 134. Eli Lilly Latest Developments

Table 135. Astrazeneca Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 136. Astrazeneca Nano-Drug Product Offered

Table 137. Astrazeneca Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 138. Astrazeneca Main Business

Table 139. Astrazeneca Latest Developments

Table 140. Johnson & Johnson Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 141. Johnson & Johnson Nano-Drug Product Offered

Table 142. Johnson & Johnson Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 143. Johnson & Johnson Main Business

Table 144. Johnson & Johnson Latest Developments

Table 145. Celgene Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 146. Celgene Nano-Drug Product Offered

Table 147. Celgene Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 148. Celgene Main Business

Table 149. Celgene Latest Developments

Table 150. Novavax Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 151. Novavax Nano-Drug Product Offered

Table 152. Novavax Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 153. Novavax Main Business

Table 154. Novavax Latest Developments

Table 155. Stryker Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 156. Stryker Nano-Drug Product Offered

Table 157. Stryker Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 158. Stryker Main Business

Table 159. Stryker Latest Developments

Table 160. Gilead Sciences Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 161. Gilead Sciences Nano-Drug Product Offered

Table 162. Gilead Sciences Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 163. Gilead Sciences Main Business

Table 164. Gilead Sciences Latest Developments

Table 165. OSI Pharmaceuticals Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 166. OSI Pharmaceuticals Nano-Drug Product Offered

Table 167. OSI Pharmaceuticals Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 168. OSI Pharmaceuticals Main Business

Table 169. OSI Pharmaceuticals Latest Developments

Table 170. Kadmon Pharmaceuticals Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 171. Kadmon Pharmaceuticals Nano-Drug Product Offered

Table 172. Kadmon Pharmaceuticals Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 173. Kadmon Pharmaceuticals Main Business

Table 174. Kadmon Pharmaceuticals Latest Developments

Table 175. Samyang Biopharm Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 176. Samyang Biopharm Nano-Drug Product Offered

Table 177. Samyang Biopharm Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 178. Samyang Biopharm Main Business

Table 179. Samyang Biopharm Latest Developments

Table 180. Mitsubishi Pharma Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 181. Mitsubishi Pharma Nano-Drug Product Offered

Table 182. Mitsubishi Pharma Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 183. Mitsubishi Pharma Main Business

Table 184. Mitsubishi Pharma Latest Developments

Table 185. Kaken Pharmaceutical Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 186. Kaken Pharmaceutical Nano-Drug Product Offered

Table 187. Kaken Pharmaceutical Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 188. Kaken Pharmaceutical Main Business

Table 189. Kaken Pharmaceutical Latest Developments

Table 190. Selecta Biosciences Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 191. Selecta Biosciences Nano-Drug Product Offered

Table 192. Selecta Biosciences Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 193. Selecta Biosciences Main Business

Table 194. Selecta Biosciences Latest Developments

Table 195. Par Pharmaceutical Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 196. Par Pharmaceutical Nano-Drug Product Offered

Table 197. Par Pharmaceutical Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 198. Par Pharmaceutical Main Business

Table 199. Par Pharmaceutical Latest Developments

Table 200. Cerulean Pharma Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 201. Cerulean Pharma Nano-Drug Product Offered

Table 202. Cerulean Pharma Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 203. Cerulean Pharma Main Business

Table 204. Cerulean Pharma Latest Developments

Table 205. Navidea Biopharmaceuticals Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 206. Navidea Biopharmaceuticals Nano-Drug Product Offered

Table 207. Navidea Biopharmaceuticals Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 208. Navidea Biopharmaceuticals Main Business

Table 209. Navidea Biopharmaceuticals Latest Developments

Table 210. Lummy Basic Information, Nano-Drug Manufacturing Base, Sales Area and Its Competitors

Table 211. Lummy Nano-Drug Product Offered

Table 212. Lummy Nano-Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 213. Lummy Main Business

Table 214. Lummy Latest Developments

List of Figures

Figure 1. Picture of Nano-Drug

Figure 2. Nano-Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Nano-Drug Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Nano-Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Nano-Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Liposomes

Figure 10. Product Picture of Polymeric Micelles

Figure 11. Product Picture of Solid lipid Nanoparticles

Figure 12. Product Picture of Microemulsion and Nanoemulsion

Figure 13. Product Picture of Nanosuspension

Figure 14. Global Nano-Drug Sales Market Share by Type in 2021

Figure 15. Global Nano-Drug Revenue Market Share by Type (2017-2022)

Figure 16. Nano-Drug Consumed in Cancer and Tumors

Figure 17. Global Nano-Drug Market: Cancer and Tumors (2017-2022) & (K Doses)

Figure 18. Nano-Drug Consumed in Autoimmune Disorders

Figure 19. Global Nano-Drug Market: Autoimmune Disorders (2017-2022) & (K Doses)

Figure 20. Global Nano-Drug Sales Market Share by Application (2017-2022)

Figure 21. Global Nano-Drug Revenue Market Share by Application in 2021

Figure 22. Nano-Drug Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Nano-Drug Revenue Market Share by Company in 2021

Figure 24. Global Nano-Drug Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Nano-Drug Revenue Market Share by Geographic Region in 2021

Figure 26. Global Nano-Drug Sales Market Share by Region (2017-2022)

Figure 27. Global Nano-Drug Revenue Market Share by Country/Region in 2021

Figure 28. Americas Nano-Drug Sales 2017-2022 (K Doses)

Figure 29. Americas Nano-Drug Revenue 2017-2022 ($ Millions)

Figure 30. APAC Nano-Drug Sales 2017-2022 (K Doses)

Figure 31. APAC Nano-Drug Revenue 2017-2022 ($ Millions)

Figure 32. Europe Nano-Drug Sales 2017-2022 (K Doses)

Figure 33. Europe Nano-Drug Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Nano-Drug Sales 2017-2022 (K Doses)

Figure 35. Middle East & Africa Nano-Drug Revenue 2017-2022 ($ Millions)

Figure 36. Americas Nano-Drug Sales Market Share by Country in 2021

Figure 37. Americas Nano-Drug Revenue Market Share by Country in 2021

Figure 38. United States Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Nano-Drug Sales Market Share by Region in 2021

Figure 43. APAC Nano-Drug Revenue Market Share by Regions in 2021

Figure 44. China Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Nano-Drug Sales Market Share by Country in 2021

Figure 51. Europe Nano-Drug Revenue Market Share by Country in 2021

Figure 52. Germany Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Nano-Drug Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Nano-Drug Revenue Market Share by Country in 2021

Figure 59. Egypt Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Nano-Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Nano-Drug in 2021

Figure 65. Manufacturing Process Analysis of Nano-Drug

Figure 66. Industry Chain Structure of Nano-Drug

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles